Showing 30,901 - 30,920 results of 107,763 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( e ((non decrease) OR (point decrease)) ))', query time: 1.50s Refine Results
  1. 30901

    DataSheet1_Effects of Real-Ambient PM2.5 Exposure on Lung Damage Modulated by Nrf2−/−.docx by Hao Ding (186871)

    Published 2021
    “…Persistent ER stress is a mechanism that causes lung damage under PM<sub>2.5</sub> exposure. …”
  2. 30902

    Image_5_Microvascular Dysfunction in Skeletal Muscle Precedes Myocardial Vascular Changes in Diabetic Cardiomyopathy: Sex-Dependent Differences.TIFF by Sadi Loai (12559255)

    Published 2022
    “…On echocardiography, all diabetic animals maintained normal ejection fraction and exhibited diastolic dysfunction, mild systolic dysfunction, and a slightly enlarged left ventricle. Exercise tolerance declined progressively and early in males (4 months), later in females (8 months); FMD showed lower baseline femoral arterial flow but unchanged reactivity in both sexes (5 months); and photoacoustic imaging showed lower tissue oxygen saturation in the legs of diabetic males (4 months) and diabetic females (10 months). …”
  3. 30903
  4. 30904
  5. 30905
  6. 30906

    Data Sheet 1_SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles.pdf by Sara Bachiller (15231716)

    Published 2025
    “…Background<p>Despite the efficacy of SARS-CoV-2 vaccines in reducing mortality and severe cases of COVID-19, a proportion of survivors experience long-term symptoms, known as post-acute sequelae of SARS-CoV-2 infection (PASC). …”
  7. 30907
  8. 30908
  9. 30909
  10. 30910
  11. 30911
  12. 30912
  13. 30913
  14. 30914

    Inactivation of the <i>Caenorhabditis elegans</i> RNF-5 E3 ligase promotes IRE-1-independent ER functions by Orit Adir (718546)

    Published 2022
    “…We demonstrate that downregulation of RNF-5 decreased sensitivity to tunicamycin both in wild type and in an <i>ire-1</i> mutant. …”
  15. 30915

    Post-losartan treatment prevented SARS-CoV-2 Spike protein-induced vascular rarefaction but not pre-losartan treatment. by Mackenzi Meier (19251139)

    Published 2024
    “…Pre-Losartan treatment showed decreased vascular density. Only post-losartan treatment showed a protective effect and restored vascular density compared to control. …”
  16. 30916

    Table_1_Five Hours Total Sleep Deprivation Does Not Affect CA1 Dendritic Length or Spine Density.pdf by Alvin T. S. Brodin (12237236)

    Published 2022
    “…Sleep deprivation has been reported to cause both decreases and increases of dendritic spine density. …”
  17. 30917

    Image_1_Five Hours Total Sleep Deprivation Does Not Affect CA1 Dendritic Length or Spine Density.TIF by Alvin T. S. Brodin (12237236)

    Published 2022
    “…Sleep deprivation has been reported to cause both decreases and increases of dendritic spine density. …”
  18. 30918

    Membrane Perturbations and Assay Interferences by Ivermectin Explain Its In Vitro SARS-CoV‑2 Antiviral Activities and Lack of Translatability by Richard T. Eastman (6051881)

    Published 2025
    “…The antiparasitic drug ivermectin was proposed as a repurposed drug for the treatment of SARS-CoV-2 infection based on in vitro studies, but proved ineffective in high-quality clinical trials. …”
  19. 30919

    Membrane Perturbations and Assay Interferences by Ivermectin Explain Its In Vitro SARS-CoV‑2 Antiviral Activities and Lack of Translatability by Richard T. Eastman (6051881)

    Published 2025
    “…The antiparasitic drug ivermectin was proposed as a repurposed drug for the treatment of SARS-CoV-2 infection based on in vitro studies, but proved ineffective in high-quality clinical trials. …”
  20. 30920

    Membrane Perturbations and Assay Interferences by Ivermectin Explain Its In Vitro SARS-CoV‑2 Antiviral Activities and Lack of Translatability by Richard T. Eastman (6051881)

    Published 2025
    “…The antiparasitic drug ivermectin was proposed as a repurposed drug for the treatment of SARS-CoV-2 infection based on in vitro studies, but proved ineffective in high-quality clinical trials. …”